These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 35759017)

  • 1. Survival outcome assessment for triple-negative breast cancer: a nomogram analysis based on integrated clinicopathological, sonographic, and mammographic characteristics.
    Sheng DL; Shen XG; Shi ZT; Chang C; Li JW
    Eur Radiol; 2022 Oct; 32(10):6575-6587. PubMed ID: 35759017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiomics features on ultrasound imaging for the prediction of disease-free survival in triple negative breast cancer: a multi-institutional study.
    Yu F; Hang J; Deng J; Yang B; Wang J; Ye X; Liu Y
    Br J Radiol; 2021 Oct; 94(1126):20210188. PubMed ID: 34478336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nomograms predicting recurrence in patients with triple negative breast cancer based on ultrasound and clinicopathological features.
    Zhang L; Zhang X; Han P; Zhao D; Hu N; Fan W; Wang P; Zuo X; Kong H; Peng F; Tian J; Cui H
    Br J Radiol; 2022 Sep; 95(1138):20220305. PubMed ID: 35819909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Nomogram to Predict Disease-Free Survival Following Neoadjuvant Chemotherapy for Triple Negative Breast Cancer.
    Zhu M; Liang C; Zhang F; Zhu L; Chen D
    Front Oncol; 2021; 11():690336. PubMed ID: 34745934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of nomograms predicting survival in Chinese patients with triple negative breast cancer.
    Yang Y; Wang Y; Deng H; Tan C; Li Q; He Z; Wei W; Zhou E; Liu Q; Liu J
    BMC Cancer; 2019 Jun; 19(1):541. PubMed ID: 31170946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an Ultrasound-based Nomogram for Predicting Pathologic Complete Response and Axillary Response in Node-Positive Patients with Triple- Negative Breast Cancer.
    Zhang M; Zha H; Pan J; Liu X; Zong M; Du L; Du Y
    Clin Breast Cancer; 2024 Aug; 24(6):e485-e494.e1. PubMed ID: 38627192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Nomogram Based on Radiomics with Mammography Texture Analysis for the Prognostic Prediction in Patients with Triple-Negative Breast Cancer.
    Jiang X; Zou X; Sun J; Zheng A; Su C
    Contrast Media Mol Imaging; 2020; 2020():5418364. PubMed ID: 32922222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a prognostic nomogram for patients with triple-negative breast cancer with histology of infiltrating duct carcinoma.
    Jing N; Ma MW; Gao XS; Liu JT; Gu XB; Zhang M; Zhao B; Wang Y; Wang XL; Jia HX
    Ann Transl Med; 2020 Nov; 8(21):1447. PubMed ID: 33313192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of sonographic features and molecular subtypes in predicting breast cancer disease outcomes.
    Wang H; Yao J; Zhu Y; Zhan W; Chen X; Shen K
    Cancer Med; 2020 Sep; 9(17):6173-6185. PubMed ID: 32657039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction for pathological and immunohistochemical characteristics of triple-negative invasive breast carcinomas: the performance comparison between quantitative and qualitative sonographic feature analysis.
    Li JW; Cao YC; Zhao ZJ; Shi ZT; Duan XQ; Chang C; Chen JG
    Eur Radiol; 2022 Mar; 32(3):1590-1600. PubMed ID: 34519862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nomograms predict survival in elderly women with triple-negative breast cancer: A SEER population-based study.
    Feng R; Huang W; Liu B; Li D; Zhao J; Yu Y; Cao X; Wang X
    Technol Health Care; 2024; 32(4):2445-2461. PubMed ID: 38306071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of prognostic nomograms using institutional data for patients with triple-negative breast cancer.
    Zhou JY; Lu KK; Fu WD; Shi H; Gu JW; Lu YQ; Guo GL
    Future Oncol; 2021 Dec; 17(36):5077-5091. PubMed ID: 34704816
    [No Abstract]   [Full Text] [Related]  

  • 13. A Web-based Prediction Model for Early Death in Patients With Metastatic Triple-negative Breast Cancer.
    Pan WK; Ren SY; Zhu LX; Lin BC
    Am J Clin Oncol; 2024 Feb; 47(2):71-80. PubMed ID: 37871164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of nomograms integrating immune-related genomic signatures with clinicopathologic features to improve prognosis and predictive value of triple-negative breast cancer: A gene expression-based retrospective study.
    Wang K; Li HL; Xiong YF; Shi Y; Li ZY; Li J; Zhang X; Li HY
    Cancer Med; 2019 Feb; 8(2):686-700. PubMed ID: 30677255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasound-based comparative analysis and nomogram development for predicting triple-negative and non-triple-negative breast cancer: a 4-year institutional study in Quanzhou First Hospital.
    Su L; Xie Q; Chen J; Zhang Q; Li N; Hong C
    BMJ Open; 2024 Jun; 14(6):e085340. PubMed ID: 38871659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nomogram for the prediction of triple-negative breast cancer histological heterogeneity based on multiparameter MRI features: A preliminary study including metaplastic carcinoma and non- metaplastic carcinoma.
    Kong QC; Tang WJ; Chen SY; Hu WK; Hu Y; Liang YS; Zhang QQ; Cheng ZX; Huang D; Yang J; Guo Y
    Front Oncol; 2022; 12():916988. PubMed ID: 36212484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors of patients with human epidermal growth factor receptor 2-positive breast cancer following neoadjuvant therapy: Development and validation of a predictive nomogram.
    Jia Z; Xing H; Wang J; Wang X; Wang X; Liu C; He J; Wu S; Miao J; Liu H; Liu Y
    Pathol Res Pract; 2024 Sep; 261():155504. PubMed ID: 39116570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Validation of Nomograms for Predicting the Prognosis of Triple-Negative Breast Cancer Patients Based on 379 Chinese Patients.
    Shi H; Wang XH; Gu JW; Guo GL
    Cancer Manag Res; 2019; 11():10827-10839. PubMed ID: 31920392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Validation of a Preoperative Magnetic Resonance Imaging Radiomics-Based Signature to Predict Axillary Lymph Node Metastasis and Disease-Free Survival in Patients With Early-Stage Breast Cancer.
    Yu Y; Tan Y; Xie C; Hu Q; Ouyang J; Chen Y; Gu Y; Li A; Lu N; He Z; Yang Y; Chen K; Ma J; Li C; Ma M; Li X; Zhang R; Zhong H; Ou Q; Zhang Y; He Y; Li G; Wu Z; Su F; Song E; Yao H
    JAMA Netw Open; 2020 Dec; 3(12):e2028086. PubMed ID: 33289845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of postoperative survival of triple-negative breast cancer based on nomogram model combined with expression of HIF-1α and c-myc.
    Cui J; Jiang H
    Medicine (Baltimore); 2019 Oct; 98(40):e17370. PubMed ID: 31577739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.